Deborah Atherly | Global Head of Policy, Access Introduction,
PATH

Deborah Atherly, PhD, BScPharm, is the Global Head of Policy, Access, and Introduction at PATH’s Center for Vaccine Innovation and Access (CVIA). She leads PATH’s global work to accelerate equitable vaccine access and introduction, shaping strategy and guiding technical portfolios across vaccines for malaria, rotavirus, typhoid, HPV, RSV, Japanese encephalitis, meningitis, pertussis, and influenza. Dr. Atherly previously specialized in the economic and financial evaluation of health technologies in low-resource settings, including global vaccine demand and supply forecasting and assessments of the health and economic impact of vaccines. She has worked extensively across sub-Saharan Africa and partners closely with Gavi, UNICEF, WHO, and national immunization programs. Before joining PATH, she held leadership roles in both the private and public sectors, conducting cost-effectiveness and return-on-investment analyses for pharmaceutical and biotechnology companies and serving in clinical pharmacy leadership positions within hospitals and health systems. Dr. Atherly is a pharmacist with a PhD in Pharmacoeconomics and Outcomes Research.